GSEU - ETF AI Analysis
Top Page
Goldman Sachs ActiveBeta Europe Equity ETF (GSEU)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Leading European Blue-Chip Holdings
Top positions like ASML, HSBC, Novartis, and other major European companies have generally shown strong or steady performance, supporting the fund’s returns.
Broad Country and Sector Diversification
The fund spreads its investments across multiple European countries and a wide mix of sectors, helping reduce the impact of problems in any single market or industry.
Negative Factors
Moderate Concentration in Top Holdings
A noticeable portion of the portfolio is tied up in a small group of large companies, which increases the fund’s sensitivity to news or setbacks affecting those names.
Lagging AstraZeneca Position
One of the top holdings, AstraZeneca, has shown weak performance this year, slightly dragging on the overall results.
Limited Exposure to Growth Sectors
The ETF has relatively small weights in technology and other high-growth areas, which may limit its ability to benefit from strong rallies in those sectors.
GSEU vs. SPDR S&P 500 ETF (SPY)
AUM119.22M
RegionEurope
Expense Ratio0.25%
Beta0.70
IssuerGoldman Sachs
Inception DateMar 02, 2016
Dividend Yield2.76%
Asset ClassEquity
Index TrackedGoldman Sachs ActiveBeta Europe Equity
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume5,410
30 Day Avg. Volume6,519
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
54.04Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering343
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GSEU Summary
GSEU is the Goldman Sachs ActiveBeta Europe Equity ETF, which follows the Goldman Sachs ActiveBeta Europe Equity index and aims to give broad exposure to European stocks of all sizes. It holds companies from many countries and sectors, including well-known names like Nestlé and HSBC, so one investment spreads your money across a wide range of businesses. Investors might consider GSEU for diversification and long-term growth in European markets. A key risk is that European stock prices can rise and fall with market and economic conditions, so the value of this ETF can go up and down over time.
How much will it cost me?The Goldman Sachs ActiveBeta Europe Equity ETF (Ticker: GSEU) has an expense ratio of 0.25%, meaning you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed funds because it uses a systematic strategy to balance multiple factors, making it more efficient than many traditional active funds.
What would affect this ETF?The GSEU ETF, which focuses on European equities, could benefit from economic recovery in Europe, increased demand for healthcare and technology innovations, and stable financial sector performance, given its significant exposure to these areas. However, it may face challenges from rising interest rates, regulatory changes in Europe, or economic slowdowns that could negatively impact industrial and consumer sectors. Its diversified holdings across developed European markets provide some resilience against sector-specific risks.
GSEU Top 10 Holdings
GSEU leans heavily on Europe’s corporate heavyweights, with Dutch chip-tool giant ASML acting as a key engine of long-term gains despite some recent wobbling. Financials like HSBC and Banco Santander are rising and help anchor the fund, while insurer Allianz adds steady strength. On the defensive side, pharma leaders Roche and Novartis are quietly supportive, even as AstraZeneca has been losing steam and Nestlé’s consumer staples muscle looks a bit tired. Overall, it’s a developed Europe story, spread across banks, health care, and industrials rather than one single superstar.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 4.07% | $4.81M | €597.04B | 127.48% | 76 Outperform | |
| HSBC Holdings | 2.07% | $2.45M | £266.83B | 61.62% | 80 Outperform | |
| Roche Holding AG | 2.03% | $2.41M | $345.58B | 34.54% | 73 Outperform | |
| Novartis AG | 1.98% | $2.34M | CHF231.67B | 37.69% | 80 Outperform | |
| AstraZeneca | 1.61% | $1.91M | $261.19B | 19.44% | 80 Outperform | |
| Banco Santander | 1.50% | $1.77M | €175.79B | 59.08% | 73 Outperform | |
| Shell (UK) | 1.38% | $1.63M | £183.16B | 21.96% | 73 Outperform | |
| Siemens | 1.24% | $1.46M | €207.53B | 21.64% | 74 Outperform | |
| Nestlé SA | 1.21% | $1.43M | CHF207.50B | 6.66% | 71 Outperform | |
| Allianz | 1.13% | $1.34M | €161.74B | 25.58% | 67 Neutral |
GSEU Technical Analysis
Positive
―
Price Trends
48.11
Positive
46.94
Positive
45.80
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSEU, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 48.60, equal to the 50-day MA of 48.11, and equal to the 200-day MA of 45.80, indicating a bullish trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSEU.
GSEU Peer Comparison
Comparison Results
Performance Comparison
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
48.77
8.13
20.00%
VGK
Vanguard FTSE Europe ETF
―
―
―
EZU
iShares MSCI Eurozone ETF
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
SPEU
SPDR Portfolio Europe ETF
―
―
―
FLEE
Franklin FTSE Europe ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents